Abuse Deterrence
Building Guardrails, Not Just Pills: Rethinking Pain Management without Abuse
David Alvaro, Ph.D.; Paul Howe
Pharma's Almanac
PAO-06-25-CL-11Jun 24, 2025
Opioid Conjugate Vaccines
Vaccines Present a Novel Strategy for Opioid Overdose Prevention
Muctarr Sesay, Ph.D.
GBI Biomanufacturing
PAO-10-022-CL-07Oct 31, 2022
Plant-Inspired Drug Discovery
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
Andrea Small-Howard, Ph.D.
Gb Sciences, Inc.
PAO-08-022-CL-01Sep 6, 2022
Column: Regulatory Spotlight
The Price of Pain: Acknowledging a Crisis and Encouraging an Alternative
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-05Jun 24, 2022
Opioid Disorder
Braeburn Submits Request for Final Approval of BRIXADI for the Treatment of Opioid Use Disorder
Braeburn
PR-M06-20-NI-014Jun 11, 2020
Movement in Cases Against Pharma Regarding the Opioid Crisis
Nice Insight
PA2120Sep 11, 2019
Opioids
Analysis of Government Data Reveals Main Players in Opioid Market
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-013Aug 7, 2019
Opioid Crisis
J&J Awaits Judge’s Decision in Lawsuit Filed by Oklahoma Over the Opioid Crisis
Nice Insight
PAO-M07-19-NI-021Jul 22, 2019
Opioid Crisis
Analysis of Medicare Prescriptions Uncovers Role Surgeons Played in Opioid Crisis
Nice Insight
PAO-M07-19-NI-002Jul 1, 2019
Opioid Crisis
Oklahoma vs. Johnson & Johnson Opioid Crisis Trial
Nice Insight
PAO-M06-19-NI-006Jun 13, 2019
Opioids
Statement on FDA’s Request for Information on Requiring Fixed-Quantity Blister Packaging for Certain Opioid Pain Medicines
PR-M06-19-NI-003Jun 5, 2019
Opioids
Top Execs at Opioid Maker Insys Therapeutics Found Guilty of Paying Bribes
Nice Insight
PAO-M05-19-NI-015May 10, 2019
Partnership
Heron Therapeutics Partners with the National Academy of Medicine to Counter the Opioid Epidemic in the United States
Heron Therapeutics, Inc.
PR-M05-19-NI-027May 9, 2019
FDA Statement
FDA Statement on New Opioid Analgesic Labeling Changes
U.S. Food & Drug Administration
PR-M04-19-NI-042Apr 12, 2019
Opioids
Generic Suboxone Sublingual Film Launched
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-004Mar 5, 2019
Opioids
Statement from FDA Commissioner Scott Gottlieb, M.D. on the Agency's 2019 policy and Regulatory Agenda for Continued Action to Forcefully Address Opioid Abuse
U.S. Food & Drug Administration
PR-M02-19-NI-061Feb 27, 2019
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on Ongoing Efforts to Secure the U.S. Supply Chain and Confront the Opioid Epidemic
U.S. Food & Drug Administration
PR-M02-19-NI-032Feb 14, 2019
Opioids
New Study Shows Physician-Targeted Marketing is Associated with Increase in Opioid Overdose Deaths
NYU Langone Health
PR-M01-19-NI-063Jan 22, 2019
Opioid Dependency
Could the Opioid Epidemic Be Relieved by a Vaccine?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-019Dec 19, 2018
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on Agency's Approval of Dsuvia and the FDA's Future Consideration of New Opioids
U.S. Food & Drug Administration
PR-M11-18-NI-016Nov 5, 2018